Stock · GEHC · Healthcare
United States · Large Cap · listed since 2023 · Revenue 12 mo. $20.2B
Price as of 11/06/2026
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Original text from the data provider
Summary
46.3 of 100
Mean of the six area values. Each area value is the mean of the stock's ranks among the companies in its sector. 50 is the middle of the sector, not a share of companies beaten.
Analysis
What the price requires
If free cash flow stays at €1.4B (2025), it supports €15B. The remaining €17.2B of the market value assume it grows 10.7% a year for 10 years and not at all afterwards.
Required FCF growth per year
10.7%
no growth afterwards
Price to operating cash flow 26.4×, above its usual range.
Middle half of 15 quarters: 16.9× to 19.7×, median 18.0×.
Measures only against its own past, not against what the company is worth. Price as of 11/06/2026.
with respect to the priced-in expectation
with respect to the priced-in expectation
Since the last quarter
Q1 → Q2 2026
6 more unchanged: Revenue, 12 mo., Gross margin, EBIT margin, Net debt, Shares outstanding, Return on equity
Derivation
Each area value is the average of its metrics' ranks within the sector (0 to 100, 50 is the middle). For metrics where lower is better, the rank is mirrored. The overall value is the average of the area values.
Price as of 11/06/2026.
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Return on equity | 20.08% | 11.52% | Rank 77 |
| Return on capital (Greenblatt) | 58.92% | 32.55% | Rank 76 |
| EBIT margin | 13.39% | 18.31% | Rank 36 |
| FCF margin | 7.30% | 14.12% | Rank 30 |
| Gross margin | 39.99% | 60.99% | Rank 24 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Revenue growth, 1 year | 4.84% | 8.04% | Rank 34 |
| Earnings growth, 3 years per year | 2.37% | 5.44% | Rank 41 |
| Earnings growth, 5 years per year | −31.69% | 7.00% | Rank 1 |
| Sustainable growth (ROE × retained earnings) | 2.34% | 3.66% | Rank 28 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Earnings yield | 5.50% | 2.90% | Rank 83 |
| FCF yield | 4.20% | 3.63% | Rank 55 |
| EV/saleslower is better | 2.00 | 4.03 | Rank 77 |
| EV/EBITlower is better | 14.97 | 21.73 | Rank 76 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Share price, 1 year | 1.46% | 8.66% | Rank 43 |
| Share price, 6 months | 30.28% | 24.27% | Rank 64 |
| Share price, 3 months | 19.91% | 15.42% | Rank 64 |
| Distance from 52-week high | −6.56% | −7.35% | Rank 53 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Accruals (Sloan)lower is better | 3.27% | 0.30% | Rank 26 |
| Change in share countlower is better | 0.28% | 0.00% | Rank 23 |
| Dividend streak in years | 2 | 10 | Rank 36 |
| Price reaction to results, market-adjusted | 6.39% | 0.05% | Rank 90 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Equity ratio | 28.12% | 48.40% | Rank 18 |
| Net debt/EBITDAlower is better | 1.45 | 1.11 | Rank 43 |
| Debt to equitylower is better | 0.96 | 0.48 | Rank 22 |
| Volatility, 1 yearlower is better | 35.21% | 31.42% | Rank 39 |
Ten years in figures
| Year | Revenue, $B | EBIT margin | FCF, $B | Shares | Net debt |
|---|---|---|---|---|---|
| 2019 | 16.6 | 12.8% | 1.7 | 455M | – |
| 2020 | 17.2 | 15.9% | 1.4 | 455M | −$539.0M |
| 2021 | 17.6 | 15.9% | 1.4 | 455M | −$119.0M |
| 2022 | 18.3 | 13.8% | 1.8 | 454M | $7.2B |
| 2023 | 19.6 | 12.5% | 1.7 | 458M | $7.4B |
| 2024 | 19.7 | 13.3% | 1.6 | 459M | $6.5B |
| 2025 | 20.6 | 13.4% | 1.5 | 460M | $5.5B |
3 of 7 StockScorer Score rules met · How the score is built
GE HealthCare Technologies Inc. mainly meets criteria in the Valuation category. Result from 18 strategies checked.
GE HealthCare Technologies Inc. is rated here with the StockScorer Score strategy, the flagship rule set. It compares return and cash-flow metrics with the median of the company's own sector and checks growth and price trend.
3 of 7 rules met
5 of 11 points
Detail data
Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.
With a free account, you can see the match across all strategies checked in one complete overview.
Selected fundamental metrics for GE HealthCare Technologies Inc.
| Metric | Stock | Sector |
|---|---|---|
| P/E ratio | 18.2 | 30.0 |
| P/B ratio | 3.7 | 4.8 |
| Return on equity (ROE) | 20.1% | 11.5% |
| Equity ratio | 28.1% | 48.4% |
| Debt-to-equity (D/E) | 0.96 | 0.48 |
| Dividend yield | 0.2% | 1.3% |
How comparable stocks in the same sector score in the StockScorer model.
| Symbol | Company | Rating |
|---|---|---|
| GEHC | GE HealthCare Technologies Inc.this page | |
| DXCM | DexCom Inc | High8.2 |
| STE | STERIS plc | Low4.5 |
| ZBH | Zimmer Biomet Holdings Inc | Low4.5 |
| GKOS | Glaukos Corp | locked |
| EW | Edwards Lifesciences Corp | locked |
Signed up in 30 seconds, free.
Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.
How StockScorer rates every stock is explained on the methodology page.